Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
MRX-502: Randomized Double-blind Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Maralixibat in the Treatment of Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC) - MARCH-PFIC (2023)
Pregnant and lactating individuals lack sufficient safety data and should consult obstetric providers before use
Semaglutide has become one of the most recognized wellness medications in recent years and is commonly discussed in personalized wellness and weight management conversations
Our bodies are able to naturally produce this powerful antioxidant, however, we can quickly become overwhelmed with toxins and other offenders that deplete glutathione
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
US$ 20.43
US$ 28.44
US$ 25.58
US$ 20.38
US$ 21.11
US$ 23.71
US$ 23.02
US$ 25.57
US$ 28.96
US$ 28.99
US$ 24.17
US$ 22.02
US$ 27.43
US$ 28.43
US$ 27.01
US$ 24.39
